U.S. Markets close in 48 mins

Cannabis Penny Stock News Release - First Canna Corp. Launches Proprietary Line of Medical Grade CBD Products

UCL to Change Name to First Canna Corp.

TAMPA, FL / ACCESSWIRE / August 1, 2019 / ​​​​​United Consortium Ltd. (UCSO), an acquisition and development Company today announced that it will change its name to First Canna Corp. to reflect its change in business direction. First Canna Corp will become a vertically integrated CBD and Medical Marijuana focused Company. The Company also announced the launch of its proprietary line of Medical Grade Full Spectrum CBD products.

UCL, soon to be First Canna Corp CEO Scott Gallagher stated, “We’ve spent the past several years evaluating opportunities in the legal Cannabis/CBD space. The passing of the farm bill really was a game changer in the industry in spite of delays with state governments relating to legal changes in Cannabis, CBDs and Hemp. The change in law allowed us to create and launch our own line of fully legal in all 50 states, Medical Grade CBD products through our new website www.FirstCannaCBD.com. We’ve partnered with an ISO certified lab to create our own line of CBD formulations targeted at potentially helping people with a variety of conditions.” Gallagher continued, “The knowledge base of CBD research is literally growing every day. We’re excited by the opportunities we see in this high growth emerging industry and look forward to building the First Canna brand.”

About United Consortium Ltd./First Canna Corp

UCL is an acquisition and development Company that will be changing its name and business focus to the legal medical marijuana/CBD space. The Company is based in Tampa, Florida. UCL is an OTC-traded Company that is working to become pink current once again. The most current information and past filings about the Company can be found on OTCMarkets.com or by visiting the Company's website at www.UCLVentures.com, www.FirstCanna.com or www.FirstCannaCBD.com.

Forward-Looking Statements

This release contains forward-looking statements that relate to future events or United Consortium Ltd. (UCL's) or First Canna Corp.’s future performance or financial condition. Any statements that are not statements of historical fact, such as the statements above and including statements containing the words "plans," "anticipates," "expects" and similar expressions, should also be considered to be forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in United Consortium Ltd.’s or First Canna Corp.’s filings with the Securities and Exchange Commission, OTC Markets or statement on the Companies websites. United Consortium Ltd. And or First Canna Corp. and all of its subsidiary companies undertakes no duty to update any forward-looking statements made herein.

Contact Information

For additional information contact:
Scott Gallagher
727-417-7807

SOURCE: Cannabis Investor Magazine



View source version on accesswire.com:
https://www.accesswire.com/554284/Cannabis-Penny-Stock-News-Release--First-Canna-Corp-Launches-Proprietary-Line-of-Medical-Grade-CBD-Products